SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-18-290456
Filing Date
2018-10-02
Accepted
2018-10-02 09:34:34
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 13584
2 GRAPHIC g548088g1001044433604.jpg GRAPHIC 2534
  Complete submission text file 0001193125-18-290456.txt   18146
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)